Dalradian Resources

Dalriada Drug Discovery is a Canadian biotechnology company and contract research organization (CRO) that provides integrated, "turn-key" drug discovery services. Headquartered in Mississauga, Ontario, the company specializes in small molecule therapeutics and supports the full discovery continuum from early target identification through to preclinical development. Dalriada leverages its proprietary iCLASS platform and advanced proteomics technologies to address challenging and "undruggable" targets, such as intrinsically disordered proteins and covalent inhibitors. The company operates with a highly specialized team, with over 70% of its scientists holding PhDs, and partners with global biotech and pharmaceutical firms to accelerate the development of novel therapies.